Wird geladen...
4CPS-110 Impact of patients’ conditions on the effectiveness and safety of erlotinib in pancreatic cancer
BACKGROUND: In post-PA studies in the use of erlotoinib, it was observed that the favourable clinical situation benefited the response to treatment. PURPOSE: To compare the effectiveness and safety of erlotinib, according to the Eastern Cooperative Oncology Group (ECOG), in pancreatic cancer. MATERI...
Gespeichert in:
| Veröffentlicht in: | Eur J Hosp Pharm |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMJ Group
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7535307/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ejhpharm-2018-eahpconf.201 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|